DNA guanine-guanine crosslinking sequence specificity of isophosphoramide mustard, the alkylating metabolite of the clinical antitumor agent ifosfamideSTRUCK, R. F; DAVIS, R. L; BERARDINI, M. D et al.Cancer chemotherapy and pharmacology. 2000, Vol 45, Num 1, pp 59-62, issn 0344-5704Article

Quality control and stability study using HPTLC : applications to cyclophosphamide in various pharmaceutical productsBOULIGAND, Jérome; STORME, Thomas; LAVILLE, Isabelle et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 1, pp 180-185, issn 0731-7085, 6 p.Article

Diastereoselective addition of 2H-2-oxo-1,4,2-oxazaphosphinanes to aldehydes and iminesPIRAT, Jean-Luc; MONBRUN, Jérome; VIRIEUX, David et al.Journal of organic chemistry. 2005, Vol 70, Num 18, pp 7035-7041, issn 0022-3263, 7 p.Article

Comments on a biochemical model of cyclophosphamide hematotoxicityPORTIER, Christopher J; PARHAM, Frederick M.Journal of toxicology and environmental health. 2000, Vol 61, Num 5-6, pp 525-528, issn 0098-4108Conference Paper

Synthesis of I-aldofosfamide-perhydrothiazinesZIMMERMANN, Jürgen; BAUER, Hans-Herwig; HOHORST, Hans-Jürgen et al.Arzneimittel-Forschung. 2000, Vol 50, Num 9, pp 843-847, issn 0004-4172Article

Evidence for a role of chloroethylaziridine in the cytotoxicity of cyclophosphamideFLOWERS, J. L; LUDEMAN, S. M; GAMESIK, M. P et al.Cancer chemotherapy and pharmacology. 2000, Vol 45, Num 4, pp 335-344, issn 0344-5704Article

Design of new oxazaphosphorine anticancer drugsJUN LIANG; MIN HUANG; WEI DUAN et al.Current pharmaceutical design. 2007, Vol 13, Num 9, pp 963-978, issn 1381-6128, 16 p.Article

Protective effects of 4-nerolidylcatechol against genotoxicity induced by cyclophosphamideVALADARES, M. C; REZENDE, K. R; PEREIRA, E. R. T et al.Food and chemical toxicology. 2007, Vol 45, Num 10, pp 1975-1978, issn 0278-6915, 4 p.Article

The effect of repeated administration of cyclophosphamide on cytochrome P450 2B in ratsAFSHARIAN, Parvaneh; TERELIUS, Ylva; HASSAN, Zuzana et al.Clinical cancer research. 2007, Vol 13, Num 14, pp 4218-4224, issn 1078-0432, 7 p.Article

DL-α-lipoic acid ameliorates cyclophosphamide induced cardiac mitochondrial injuryMYTHILI, Y; SUDHARSAN, P. T; VARALAKSHMI, P et al.Toxicology (Amsterdam). 2005, Vol 215, Num 1-2, pp 108-114, issn 0300-483X, 7 p.Article

Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthaseLOEFFLER, Markus; KRÜGER, Jörg A; REISFELD, Ralph A et al.Cancer research (Baltimore). 2005, Vol 65, Num 12, pp 5027-5030, issn 0008-5472, 4 p.Article

Schnitzler's syndrome treated successfully with intravenous pulse cyclophosphamidePETERLANA, D; PUCCETTI, A; TINAZZI, E et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 4, pp 328-330, issn 0300-9742, 3 p.Article

Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in ratsYILDIRIM, Ibrahim; KORKMAZ, Ahmet; OTER, Sukru et al.Cancer chemotherapy and pharmacology. 2004, Vol 54, Num 5, pp 469-473, issn 0344-5704, 5 p.Article

Influence of age upon ifosfamide-induced nephrotoxicityMCCUNE, Jeannine S; FRIEDMAN, Debra L; SCHUETZE, Scott et al.Pediatric blood & cancer. 2004, Vol 42, Num 5, pp 427-432, issn 1545-5009, 6 p.Article

High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBOULIGAND, Jérome; PACI, Angelo; MERCIER, Lionel et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 3, pp 525-530, issn 0731-7085, 6 p.Article

Effectiveness of a closed-system device in containing surface contamination with cyclophosphamide and ifosfamide in an i.v. admixture areaCONNOR, Thomas H; ANDERSON, Roger W; SESSINK, Paul J et al.American journal of health-system pharmacy. 2002, Vol 59, Num 1, pp 68-72, issn 1079-2082Article

Toxicity of chloroacetaldehyde is similar in adult and pediatric kidney tubulesDUBOURG, Laurence; TANIERE, Philippe; COCHAT, Pierre et al.Pediatric nephrology (Berlin, West). 2002, Vol 17, Num 2, pp 97-103, issn 0931-041XArticle

Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcomaPETRIOLI, Roberto; CORATTI, Andrea; PIRTOLI, Luigi et al.American journal of clinical oncology. 2002, Vol 25, Num 5, pp 468-473, issn 0277-3732, 6 p.Article

Analysis of potential porcine endogenous retrovirus (PERV) transmission in a whole-organ xenotransplantation model without interfering microchimerismLOSS, Martin; ARENDS, Heiko; WINKLER, Michael et al.Transplant international. 2001, Vol 14, Num 1, pp 31-37, issn 0934-0874Article

Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its MetabolitesKERBUSCH, Thomas; DE KRAKER, Jan; KEIZER, H. Jan et al.Clinical pharmacokinetics. 2001, Vol 40, Num 1, pp 41-62, issn 0312-5963Article

Ciclofosfamida a dosis escaladas en tumores sólidos malignos en población pediátrica. Experiencia en el Hospital Infantil de México Federico Gómez = Cyclophosphamide dose escalation in solid tumors in childrenJUAREZ-VILLEGAS, L. E; MEDINA-SANSON, A; PERALES-ARROYO, A et al.Boletín Médico del Hospital Infantil de México (Ed. española). 1999, Vol 56, Num 6, pp 313-317, issn 0539-6115Article

Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiencyBRANTEN, A. J. W; REICHERT, L. J. M; KOENE, R. A. P et al.QJM (Oxford. 1994. Print). 1998, Vol 91, Num 5, pp 359-366, issn 1460-2725Article

The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration : a randomized cross-over studySINGER, J. M; HARTLEY, J. M; BRENNAN, C et al.British journal of cancer. 1998, Vol 77, Num 6, pp 978-984, issn 0007-0920Article

Immunosurgical studies on cytological and cytogenetic toxicity analysis of rat blastocysts after in vivo exposure to cyclophosphamideLOU, Y.-J; HONG, Y.Zhōngguó yàoli xuébào. 1997, Vol 18, Num 3, pp 259-262, issn 0253-9756Article

Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamideGERMANN, N; URIEN, S; RODGERS, Andrew H et al.Cancer chemotherapy and pharmacology. 2005, Vol 55, Num 2, pp 143-151, issn 0344-5704, 9 p.Article